Product NDC: | 16590-883 |
Proprietary Name: | BRIMONIDINE TARTRATE |
Non Proprietary Name: | BRIMONIDINE TARTRATE |
Active Ingredient(s): | 2 mg/mL & nbsp; BRIMONIDINE TARTRATE |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16590-883 |
Labeler Name: | STAT RX USA LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076260 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030528 |
Package NDC: | 16590-883-10 |
Package Description: | 10 mL in 1 BOTTLE, DROPPER (16590-883-10) |
NDC Code | 16590-883-10 |
Proprietary Name | BRIMONIDINE TARTRATE |
Package Description | 10 mL in 1 BOTTLE, DROPPER (16590-883-10) |
Product NDC | 16590-883 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | BRIMONIDINE TARTRATE |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 20030528 |
Marketing Category Name | ANDA |
Labeler Name | STAT RX USA LLC |
Substance Name | BRIMONIDINE TARTRATE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |